Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
Intuitive Surgical is initiated with a Buy rating and a $584.87 price target, reflecting 19% upside potential. ISRG's business model benefits from robust recurring revenues in consumables and services, with continued growth in robotic surgery adoption and international expansion. Margins faced temporary pressure from tariffs and the Da Vinci 5 rollout, but operating margins remained resilient and are expected to stabilize by 2026.
Intuitive Surgical - Strong Moat But Valuation Remains Elevated, Hold
Intuitive Surgical (ISRG) remains the robotic-assisted surgery market leader, with Q4 procedures up 18% and revenue rising 19% to $2.87 billion. ISRG's recurring revenue model, high margins, and $3B net cash underpin a robust balance sheet and significant moat. Despite strong fundamentals, ISRG trades at a P/E of 63 versus its 53.5 historical average, justifying a Hold rating amid recent technical weakness.
Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Intuitive Surgical Expands Direct Operational Presence in Europe
ISRG expands in Europe after acquiring da Vinci and Ion distribution across Italy, Spain and Portugal, integrating operations to directly support customers.
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
Intuitive Surgical's My Intuitive+ may turn paid in 2026, adding a software-driven revenue layer as renewals begin and digital engagement scales.
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now?
Both ISRG and ABT closed 2025 on a strong note, but Intuitive Surgical's surging procedure growth and innovation may give it the edge for long-term gains.
Top Robotics Stocks Worth Investing Now for Solid Returns
Nvidia's bold CES 2026 push into physical AI underscores a robotics boom as funding, factory adoption and humanoid rollouts fuel a pivotal growth cycle.
ISRG's International Growth Outpaces US With 35% Procedure Volume
Intuitive Surgical sees international procedures jump 23% in 2025, now 35% of total, outpacing U.S. growth and reshaping its long-term expansion strategy.
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
